Application of Anlotinib Combined With Neoadjuvant Chemotherapy in Primary EWS/PNET of Lung: A Case Report

Primary pulmonary EWS/PNET(PPES) is extremely rare and is associated with a poor prognosis. Tumor angiogenesis plays an important role in tumor, so it has become a hot topic in molecular targeted therapy. Anlotinib is a new oral small molecular multi-targeted receptor tyrosine kinase (RTK) inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, YH, Ma, HX, Guo, SP, Chen, Y, Zhang, SP
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069099/
https://www.ncbi.nlm.nih.gov/pubmed/35530342
http://dx.doi.org/10.3389/fonc.2022.822469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069099/
https://www.ncbi.nlm.nih.gov/pubmed/35530342
http://dx.doi.org/10.3389/fonc.2022.822469

Ejemplares similares